期刊文献+

卵巢上皮性肿瘤CD_(105)标记的微血管密度的研究

The study of microvessel density marked with CD_(105)in epithelial ovarian tumour
原文传递
导出
摘要 目的探讨卵巢上皮性肿瘤CD105表达及其标记的微血管密度(MVD)与肿瘤发生、发展的关系。方法应用免疫组织化学法检测25例良性肿瘤,10例交界性肿瘤和24例恶性上皮性肿瘤中CD105的表达及MVD。结果59例卵巢上皮性肿瘤中,CD105标记的MVD在恶性肿瘤中显著高于交界性及良性肿瘤(P<0.01),CD105标记的恶性肿瘤中MVD与肿瘤临床分期、病理分级、患者年龄无统计学相关性(P>0.05)。结论CD105标记的MVD与卵巢上皮性肿瘤恶性进展相关,但不能作为卵巢上皮性恶性肿瘤的预后指标。 Objective To investigate the correlation between microvessel density (MVD) marked with CD105 and the development of epithelial ovarian tumour. Methods Expression of CD105 protein and MVD were examined by immunonistochemical technique in 25 cases of benign tumour, 10 cases of borderline tumour and 24 cases of malignant epithelial ovarian tumours. Results The average MVD was higher in the malignant cases than those in benign and borderline cases (P 〈 0.01).The MVD were not related to the tumour's pathological grade,clinical stage and patient's age (P 〉 0.05). Conclusion The MVD labeled by CD105 is correlated with progression of epithelial ovarian tumour, MVD in epithelial ovarian tumour can not act as predictor factor.
出处 《中国医师进修杂志》 2006年第7期3-4,7,共3页 Chinese Journal of Postgraduates of Medicine
关键词 卵巢上皮性肿瘤 CD105 微血管密度 Epithelial ovarian tumour CD105 Mierovessel density
  • 相关文献

参考文献10

  • 1Wikstrom P,Lissbrant IF,Stattin P,et al.Endoglin(CD105) is expressed on immature blood vessels and is a marker for survival in prostate cancer.Prostate, 2002,51(4):268-275.
  • 2Korkolopoulou P, Patsouris E, Kavantzas N, et al.Prognostic implications of mierovessel morphometry in diffuse astrocytie neoplasms.Neu ropathol Appl Neurobiol, 2002,28(1):57-66.
  • 3鹿群.CD105在恶性肿瘤诊断、预后及治疗中的意义[J].国外医学(肿瘤学分册),2002,29(5):358-360. 被引量:4
  • 4Sharma S, Sharma MC, Sarkar C. Morphology of angiogenesis in human cancer:aconceptualoverview, histoprognostic perspective and significance of neoangiogenesis. Histopathology, 2005, 46(5):481-489.
  • 5Hayrabedyan S, Kyurkchiev S,Kehayov LEndoglin (CD105) and S100A13 as markers of active angiogenesis in endometriosis. Reprod Bid,2005,5(1):51-67.
  • 6Duffy JP, Eibl G, Reber HA, et al. Influence of hypoxia and neoangio-genesis on the growth of pancreatic cancer. Mol Cancer, 2003, 22(1):12-16.
  • 7Fonsatti E,Maio M. Highlights on endoglin (CD105): from basic findings towards clinical applications in human cancer. J Transl Med,2004,2(1):18.
  • 8景元明,周士福.CD105标记的微血管密度及血管内皮生长因子在胃癌中的表达[J].河北医学,2004,10(1):1-5. 被引量:9
  • 9庞达,刘锋,薛英威,张岂凡.乳腺癌组织中CD105 mRNA的表达及其临床病理意义[J].中华肿瘤杂志,2005,27(1):38-40. 被引量:15
  • 10postiglione L,Domenico G,Garaglia M,et al.Differential expression and cytoplasm / membrane distribution of endoglin (CD105) in human tumor cell lines: implications in the modulation of cell proliferation.Int J Oned, 2005,26(5): 1193-1201.

二级参考文献37

  • 1Wikstrom P,Lissbrant IF,Stattin P,et al.CD105(CD105)is exprssed on immature blood Vessels and is a marker for survival in prostate cancer[J].Prostate,2002,51(4):268-275
  • 2Seon BK,Matsuno F,Haruta Y,et al.Long-lasting comoplete inhibition of human solid tumors in SCID mice by targeting endothelial cells of tumor varsculature with antihuman CD105 immunotoxin[J].Clin Cancer Res,1997,:1031-1044
  • 3Fumihiro Tanaka,et al.Correlalion Between apoptotic index and agiogenesis in non - small cell lung cancer:comparison between CD105 and CD34 as a marker as agiogenesis[J].Lung Cancer,2003,39:289-296
  • 4Pruneri Giancarlo,et al.Microvessel density,a surrogate marker of angiogenesis,is significantly related to survival in multiple myeloma patients[J].Blackwell Science Ltd.Volume 118(3):September,2002,817-820
  • 5Miler DW,Graulich W,Karges B,et al.Elevated expression of CD105,a component of the TGF-beta-receptor complex,correlates with proliferation of tumor CD105 cells[J].Int J Cancer,1999,81(4):568-572
  • 6Li C,et al.CD105 is a biomarker for colorectal cancer prognosis[J].Cancer Weekly,7/15/2003,p42,2p.
  • 7Vermeulen PB,Gasparini G,Fox PB,et al.Quantification of angiogenesis in solid human tumors:an intemational consensus on the methodology and criteria of evaluation[J].Eur J Cancer 1996,32A:2474/84
  • 8Baillie CT,Winslet MQ,Bradley NJ.Tumor vasculature-apotential therapeutic target[J].Brit J Cancer,1995,72
  • 9Li DY, Sorensen LK, Brooke BS, et al. Defective angiogenesis in mice lacking endoglin. Scinece, 1999, 284: 1534-1537.
  • 10Miller DW, Graulich W, Karges B, et al. Elevated expression of endoglin, a component of the TGF-beta-receptor complex, correlates with proliferation of tumor endothelial cell. Int J Cancer, 1999, 81:568-572.

共引文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部